Your browser doesn't support javascript.
loading
Comparison of bone mineral loss by combined androgen block agonist versus GnRH in patients with prostate cancer: A 12 month-prospective observational study.
Kim, Sung Han; Joung, Jae Young; Kim, Sohee; Rha, Koon Ho; Kim, Hyeong Gon; Kwak, Cheol; Lee, Ji Youl; Jeon, Seong Soo; Hong, Sung Kyu; Jeong, Hyeon; Jo, Moon Ki; You, Dalsan; Jeong, In Gab; Hong, Jun Hyuk; Kim, Choung-Soo.
Afiliación
  • Kim SH; Department of Urology, Prostate Cancer Center, National Cancer Center, Goyang, Republic of Korea.
  • Joung JY; Department of Urology, Prostate Cancer Center, National Cancer Center, Goyang, Republic of Korea.
  • Kim S; Department of Urology, Prostate Cancer Center, National Cancer Center, Goyang, Republic of Korea.
  • Rha KH; Department of Urology and Urological Science Institute, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Kim HG; Department of Urology, Konkuk University School of Medicine, Konkuk University Medical Center, Seoul, Republic of Korea.
  • Kwak C; Department of Urology, Seoul National University Hospital, Seoul, Republic of Korea.
  • Lee JY; Department of Urology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
  • Jeon SS; Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Hong SK; Department of Urology, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
  • Jeong H; Department of Urology, Seoul Metropolitan Government, Seoul National University Boramae Medical Center, Seoul, Republic of Korea.
  • Jo MK; Department of Urology, Korea Cancer Centre Hospital, Seoul, Republic of Korea.
  • You D; Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Jeong IG; Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Hong JH; Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Kim CS; Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Sci Rep ; 7: 39562, 2017 03 06.
Article en En | MEDLINE | ID: mdl-28262724
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Densidad Ósea / Hormona Liberadora de Gonadotropina / Fracturas Óseas / Antagonistas de Andrógenos Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Aged80 / Humans / Male / Middle aged Idioma: En Revista: Sci Rep Año: 2017 Tipo del documento: Article Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Densidad Ósea / Hormona Liberadora de Gonadotropina / Fracturas Óseas / Antagonistas de Andrógenos Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Aged80 / Humans / Male / Middle aged Idioma: En Revista: Sci Rep Año: 2017 Tipo del documento: Article Pais de publicación: Reino Unido